Jeffrey A. Meckler
Board Member
Indaptus Therapeutics, Inc. (INDP)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Jeffrey A. Meckler
Jeffrey A. Meckler is recorded as CEO and Board Member at Indaptus Therapeutics, Inc. (INDP). Indaptus Therapeutics, Inc. reported in an 8-K filed March 24, 2026 that Jeffrey A. Meckler resigned as co-Chief Executive Officer, effective March 18, 2026. Indaptus Therapeutics, Inc. reported in an 8-K filed March 24, 2026 that Jeffrey A. Meckler resigned as Director, effective March 18, 2026. Indaptus Therapeutics, Inc. reported in an 8-K filed December 23, 2025 that Jeffrey A. Meckler was appointed Co-Chief Executive Officer, effective December 22, 2025. Equibles holds 4 filed executive changes naming Jeffrey A. Meckler; each is listed under recent activity with its source filing. The proxy statement of Indaptus Therapeutics, Inc. reports total compensation of $1,001,249 for Jeffrey A. Meckler in fiscal 2023, including a base salary of $565,000. Disclosed compensation is on record for 4 fiscal years.
“Mr. Meckler also resigned as co-Chief Executive Officer on March 18, 2026.”
“Jeffrey A. Meckler, Roger J. Pomerantz, Anthony J. Maddaluna, and William B. Hayes (together, the "Resigning Directors") resigned on March 18, 2026.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2025-12-22–present
-
Current
2024-06-06–present
-
2024-06-06–2026-03-18
-
2021-01-01–2026-03-18
-
Start not stated–2026-03-18
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Indaptus Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- David E. Lazar CEO, Chairman
- David Lazar CEO, Chairman, Board Member
- Jeffrey Meckler CEO
- Junyi Dai CEO, Chairman, Board Member
- Roger J. Pomerantz Chairman, Board Member
- Yu Ding CFO
- Walt A. Linscott COO
- Anthony J. Maddauluna Board Member
- Avraham Ben-Tzvi Board Member
- David Natan Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2023 | Indaptus Therapeutics, Inc. (INDP) | Chief Executive Office ^)^ | $565,000 | $1,001,249 |
| 2022 | Indaptus Therapeutics, Inc. (INDP) | Chief Executive Office ^)^ | $552,000 | $1,680,532 |
| 2021 | Indaptus Therapeutics, Inc. (INDP) | Chief Executive Officer | $540,000 | $1,412,237 |
| 2020 | Indaptus Therapeutics, Inc. (INDP) | Chief Executive Officer | $540,000 | $1,066,243 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.